Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry model.

Torgeman A, Schwartz A, Diamant E, Baruchi T, Dor E, Ben David A, Pass A, Barnea A, Tal A, Rosner A, Rosen O, Zichel R.

Dis Model Mech. 2018 Sep 27;11(9). pii: dmm035089. doi: 10.1242/dmm.035089.

2.

A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.

Diamant E, Pass A, Rosen O, Ben David A, Torgeman A, Barnea A, Tal A, Rosner A, Zichel R.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02379-17. doi: 10.1128/AAC.02379-17. Print 2018 Apr.

3.

An in vitro cell-based potency assay for pharmaceutical type A botulinum antitoxins.

Torgeman A, Diamant E, Levin L, David AB, Epstein E, Girshengorn M, Mazor O, Rosenfeld R, Zichel R.

Vaccine. 2017 Dec 19;35(52):7213-7216. doi: 10.1016/j.vaccine.2017.11.015. Epub 2017 Nov 22.

PMID:
29174678
4.

Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations.

Torgeman A, Ozeri E, Ben David A, Diamant E, Rosen O, Schwartz A, Barnea A, Makovitzki A, Mimran A, Zichel R.

Toxins (Basel). 2017 May 29;9(6). pii: E180. doi: 10.3390/toxins9060180.

5.

Early, Real-Time Medical Diagnosis of Botulism by Endopeptidase-Mass Spectrometry.

Rosen O, Feldberg L, Gura S, Brosh-Nissimov T, Guri A, Zimhony O, Shapiro E, Beth-Din A, Stein D, Ozeri E, Barnea A, Turgeman A, Ben David A, Schwartz A, Elhanany E, Diamant E, Yitzhaki S, Zichel R.

Clin Infect Dis. 2015 Dec 15;61(12):e58-61. doi: 10.1093/cid/civ861. Epub 2015 Sep 28.

PMID:
26420800
6.

Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs.

Diamant E, Torgeman A, Ozeri E, Zichel R.

Toxins (Basel). 2015 May 29;7(6):1854-81. doi: 10.3390/toxins7061854. Review.

7.

Evaluating the synergistic neutralizing effect of anti-botulinum oligoclonal antibody preparations.

Diamant E, Lachmi BE, Keren A, Barnea A, Marcus H, Cohen S, David AB, Zichel R.

PLoS One. 2014 Jan 27;9(1):e87089. doi: 10.1371/journal.pone.0087089. eCollection 2014.

8.

The receptor binding domain of botulinum neurotoxin serotype A (BoNT/A) inhibits BoNT/A and BoNT/E intoxications in vivo.

Ben David A, Diamant E, Barnea A, Rosen O, Torgeman A, Zichel R.

Clin Vaccine Immunol. 2013 Aug;20(8):1266-73. doi: 10.1128/CVI.00268-13. Epub 2013 Jun 12.

9.

Unveiling the mystery of visual information processing in human brain.

Diamant E.

Brain Res. 2008 Aug 15;1225:171-8. doi: 10.1016/j.brainres.2008.05.017. Epub 2008 May 18. Review.

PMID:
18585686
10.

Towards the definition of pathogenic microbe.

Danin-Poleg Y, Somer L, Cohen LA, Diamant E, Palti Y, Kashi Y.

Int J Food Microbiol. 2006 Dec 1;112(3):236-43. Epub 2006 Aug 17.

PMID:
16919836
11.

Amplified intergenic locus polymorphism as a basis for bacterial typing of Listeria spp. and Escherichia coli.

Somer L, Danin-Poleg Y, Diamant E, Gur-Arie R, Palti Y, Kashi Y.

Appl Environ Microbiol. 2005 Jun;71(6):3144-52.

13.

Class switch recombination in B lymphopoiesis: a potential pathway for B cell autoimmunity.

Diamant E, Melamed D.

Autoimmun Rev. 2004 Aug;3(6):464-9. Review.

PMID:
15351312
14.

Phylogeny and strain typing of Escherichia coli, inferred from variation at mononucleotide repeat loci.

Diamant E, Palti Y, Gur-Arie R, Cohen H, Hallerman EM, Kashi Y.

Appl Environ Microbiol. 2004 Apr;70(4):2464-73.

15.

Modification of ligand-independent B cell receptor tonic signals activates receptor editing in immature B lymphocytes.

Keren Z, Diamant E, Ostrovsky O, Bengal E, Melamed D.

J Biol Chem. 2004 Apr 2;279(14):13418-24. Epub 2003 Dec 10.

16.

Impaired immunity to pneumococcal polysaccharide antigens in children with human immunodeficiency virus infection immunized with pneumococcal vaccine.

Peters VB, Diamant EP, Hodes DS, Cimino CO.

Pediatr Infect Dis J. 1994 Oct;13(10):933-4. No abstract available.

PMID:
7854897
17.

Evaluation of prophylaxis against invasive pneumococcal infections in human immunodeficiency virus-infected children.

Peters VB, Hyatt AC, Schechter C, Diamant EP, Hodes DS.

Pediatr Infect Dis J. 1994 Jul;13(7):667-9. No abstract available. Erratum in: Pediatr Infect Dis J 1994 Nov;13(11):958.

PMID:
7970963
18.

Immunogenicity of hepatitis B vaccine in human immunodeficiency virus-infected children.

Diamant EP, Schechter C, Hodes DS, Peters VB.

Pediatr Infect Dis J. 1993 Oct;12(10):877-8. No abstract available.

PMID:
7904336
19.

Chronic epiglottitis in a child with acquired immunodeficiency syndrome.

Diamant EP, Dische RM, Barzilai A, Hodes DS, Peters VB.

Pediatr Infect Dis J. 1992 Sep;11(9):770-1. No abstract available.

PMID:
1448321
20.

Brain ribosomal RNA synthesis inhibited by chlorpromazine.

Breitbart H, Perl M, Mayevsky A, Diamant EY.

Proc Soc Exp Biol Med. 1973 May;143(1):204-7. No abstract available.

PMID:
4703431
21.

[Use of a panel reflexograph in assessing the effect of pulsed vibrations on the organism].

Cherniuk VI, Diamant EM.

Vrach Delo. 1969 Nov;11:99-101. Russian. No abstract available.

PMID:
5384433
22.

Changes in patterns of enzymes of carbohydrate metabolism in the developing rat liver.

BURCH HB, LOWRY OH, KUHLMAN AM, SKERJANCE J, DIAMANT EJ, LOWRY SR, VON DIPPE P.

J Biol Chem. 1963 Jul;238:2267-73. No abstract available.

23.

Effect of handling on the thyroid-ectomized rat.

ELRICK H, BORDA-BOSSANA D, DIAMANT E, BERNSTEIN L, WHITEHOUSE JM.

Am J Physiol. 1960 Jan;198:13-4. No abstract available.

PMID:
13820094
24.

Body composition of rats in B-vitamin deficiencies.

GUGGENHEIM K, DIAMANT EJ.

Br J Nutr. 1959;13(1):61-7. No abstract available.

PMID:
13628940
25.

Effects of handling on the adrenalectomized rat.

ELRICK H, BERNSTEIN L, DIAMANT E, WHITEHOUSE JM, BORDA-BOSSANA D.

Proc Soc Exp Biol Med. 1958 Dec;99(3):696-8. No abstract available.

PMID:
13614470
26.

Effects of 3-acetylpyridine on metabolism of nicotinic acid in rats.

GUGGENHEIM K, DIAMANT EJ.

Biochem J. 1958 May;69(1):56-9. No abstract available.

27.

Carbohydrate metabolism in emetine-poisoned rats.

DIAMANT EJ.

J Pharmacol Exp Ther. 1958 Apr;122(4):465-73. No abstract available.

PMID:
13539773
28.

Electrolyte metabolism in pyridoxine, riboflavin and pantothenic acid-deficient rats.

DIAMANT EJ, GUGGENHEIM K.

Am J Physiol. 1957 Oct;191(1):108-12. No abstract available.

PMID:
13478694
29.

Carbohydrate metabolism in pyridoxine-deficient rats.

GUGGENHEIM K, DIAMANT EJ.

J Biol Chem. 1957 Feb;224(2):861-9. No abstract available.

30.

Effect of riboflavin and choline deficiencies on water metabolism in rats.

GUGGENHEIM K, DIAMANT EJ.

J Nutr. 1955 Oct 10;57(2):249-60. No abstract available.

PMID:
13272067
31.

The effect of antibiotics on the metabolism of B vitamins.

GUGGENHEIM K, HALEVY S, DIAMANT EJ.

Harefuah. 1955 Sep 15;49(6):139-42. No abstract available.

PMID:
13318540
32.

Studies on vitamin metabolism in emetine poisoning.

DIAMANT EJ, HALEVY S, GUGGENHEIM K.

J Nutr. 1955 Feb 10;55(2):241-53. No abstract available.

PMID:
14354462
33.

The effect of antibiotics on the metabolism of nicotinic acid, biotin and folic acid in rats.

HALEVY S, DIAMANT EJ, GUGGENHEIM K.

Br J Nutr. 1955;9(1):57-62. No abstract available.

PMID:
14351661

Supplemental Content

Loading ...
Support Center